The new EchoHeart® is the first transvaginal audio Doppler probe in
the world. It is intended as an economical and convenient method to
determine fetal viability in very early stages of pregnancy. With
EchoHeart you can determine fetal viability as early as 6 weeks. No
special training is required since the probe shape and placement
are similar to transvaginal imaging probes. The new EchoHeart helps
streamline your practice by reducing the need for costly imaging
exams when conventional Dopplers can not detect the fetal
heartbeat. There is no need to schedule additional imaging exams.
Prior to EchoHeart the only option was imaging. EchoHeart is
perfect for high-risk (multiple viability exams), retroverted
uterus or obese patients. The EchoHeart probe can quickly be
interchanged with standard Summit Doppler 2 and 3 MHz probes,
maximizing your equipment investment. (EchoHeart will not work with
Dopplers manufactured by other companies). While the EchoHeart is
not intended to replace imaging equipment, it can economically
provide heartbeat detection in early stages of pregnancy. In a
recent study, clinicians using EchoHeart were able to detect fetal
heartbeats in 71% of patients between 6 and 8 weeks. Backed by the
same unequaled customer service as our other Doppler systems, the
EchoHeart will be a worry-free addition to any women's clinic.
MORE
DETAILS
Probe only--WORKS ONLY WITH SUMMITT DOPPLERS